Company page

Enanta Pharmaceuticals, Inc.

Enanta Pharmaceuticals, Inc. (Ticker: ENTA) is a public company based in the United States, focusing on the development of innovative therapies for viral infections and liver diseases. With a market capitalization of approximately $371.6 million, Enanta is committed to advancing its pipeline of drug candidates to address unmet medical needs. The company is actively engaged in research and development to bring new treatments to market.